GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RAMM Pharma RAMM.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.02

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$3.4m

FY2018FY2025

Net income

−C$8.9m

FY2018FY2025

Free cash flow

−C$1.1m

FY2018FY2025

Shareholders' equity

C$5.7m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueC$3.4mC$4.3mC$5.1mC$3.9mC$4.1mC$5.4mC$5.6mC$8.3m
Operating income−C$4.3m−C$6.7m−C$7.1m−C$7.9m−C$6.6m−C$7.6m−C$5.5mC$332,738
Net income−C$8.9m−C$16.5m−C$7.7m−C$21.0m−C$7.1m−C$7.4m−C$6.8m−C$684,582
Diluted earnings per share-0.07-0.14-0.06-0.17-0.06-0.07-0.07-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsC$9.3mC$16.7mC$32.3mC$39.3mC$59.7mC$37.2mC$42.7mC$6.9m
Total liabilitiesC$3.6mC$3.1mC$2.8mC$3.7mC$3.3mC$1.3mC$4.6mC$7.2m
Debt———————C$1.4m
Shareholders' equityC$5.7mC$13.6mC$29.5mC$35.6mC$56.4mC$35.8mC$38.1m−C$226,902
Shares outstanding119m119m119m122m123m100m101m101m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−C$1.1m−C$4.0m−C$4.3m−C$5.9m−C$3.8m−C$2.9m−C$1.8mC$1.7m
Capital spending—−C$47,431−C$62,175−C$167,852−C$430,357−C$276,871−C$387,909−C$20,707
Free cash flow−C$1.1m−C$4.0m−C$4.4m−C$6.1m−C$4.3m−C$3.2m−C$2.2mC$1.7m

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
RevenueC$260,013C$190,498C$212,723C$605,662C$883,200C$861,614C$1.0mC$1.0m
Operating income−C$968,708−C$824,091−C$934,118−C$1.3m−C$948,500−C$839,884−C$1.2m−C$2.5m
Net income−C$887,316−C$276,899−C$758,515−C$7.2m−C$523,100−C$207,340−C$1.0m−C$11.5m
Diluted earnings per share-0.01-0.00-0.01-0.06-0.00-0.00-0.01-0.10
Total assetsC$6.7mC$7.1mC$8.4mC$9.3mC$14.9mC$15.6mC$15.6mC$16.7m
Cash and short-term investments————C$529,400———
Shareholders' equityC$3.7mC$4.3mC$4.9mC$5.7mC$12.4mC$12.7mC$12.4mC$13.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.8%-9.2%—
Operating income-18.5%-10.7%—
Net income-24.8%3.7%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-143.3%-156.2%-153.5%—
Net margin-329.9%-324.6%-261.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-0.1—-0.0-0.0-0.1-0.1
Price to sales0.10.00.00.00.10.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.